Search hospitals
>
New Hampshire
>
Lebanon
Dartmouth-Hitchcock Medical Center
Claim this profile
Lebanon, New Hampshire 03766
Global Leader in Lung Cancer
Global Leader in Cancer
Conducts research for Breast Cancer
Conducts research for Pancreatic Cancer
Conducts research for Non-Small Cell Lung Cancer
1082 reported clinical trials
83 medical researchers
Summary
Dartmouth-Hitchcock Medical Center is a medical facility located in Lebanon, New Hampshire. This center is recognized for care of Lung Cancer, Cancer, Breast Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer and other specialties. Dartmouth-Hitchcock Medical Center is involved with conducting 1,082 clinical trials across 1,271 conditions. There are 83 research doctors associated with this hospital, such as Julie Kim, Kathryn C. Hourdequin, Konstantin H. Dragnev, and Manik A. Amin.
Area of expertise
Lung Cancer
Dartmouth-Hitchcock Medical Center has run 91 trials for Lung Cancer. Some of their research focus areas include:
Cancer
Dartmouth-Hitchcock Medical Center has run 83 trials for Cancer. Some of their research focus areas include:
Top PIs
Julie Kim
Dartmouth Hitchcock Medical Center
8 years of reported clinical research
Kathryn C. Hourdequin
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
9 years of reported clinical research
Konstantin H. Dragnev
Dartmouth Hitchcock Medical Center
6 years of reported clinical research
Manik A. Amin
Washington University School of Medicine
7 years of reported clinical research
Clinical Trials running at Dartmouth-Hitchcock Medical Center
Cancer
Lung Cancer
Multiple Myeloma
Breast Cancer
Brain Tumor
Non-Small Cell Lung Cancer
Heart Attack
Pancreatic Cancer
Abdominal Aortic Aneurysm
Idiopathic Pulmonary Fibrosis
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine + Bevacizumab as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting
2 awards
Phase 3
Bria-IMT + CPI
for Advanced Breast Cancer
This is a multicenter randomized, open label study to evaluate overall survival with the Bria-IMT regimen in combination with Checkpoint Inhibitor \[Retifanlimab\], versus Treatment of Patients'/Physicians' Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies available.
Recruiting
2 awards
Phase 3
6 criteria
Alintegimod + Ipilimumab + Nivolumab
for Cancer
This study is an open-label Phase Ib (Part A) dose escalation followed by a blinded, randomized, multi cohort Phase 2a (Part B) comparison of combination vs. reference regimens. Currently study will only be enrolling the Phase 1b and the Phase 2a protocol requirements will be added to the study near completion of the Phase 1b
Recruiting
1 award
Phase 1 & 2
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Dartmouth-Hitchcock Medical Center?
Dartmouth-Hitchcock Medical Center is a medical facility located in Lebanon, New Hampshire. This center is recognized for care of Lung Cancer, Cancer, Breast Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer and other specialties. Dartmouth-Hitchcock Medical Center is involved with conducting 1,082 clinical trials across 1,271 conditions. There are 83 research doctors associated with this hospital, such as Julie Kim, Kathryn C. Hourdequin, Konstantin H. Dragnev, and Manik A. Amin.
Where is Dartmouth-Hitchcock Medical Center located?
**Directions to Dartmouth-Hitchcock Medical Center, Lebanon, NH:** - From I-89, take Exit 18 and follow Route 120 for about 3 miles. Look for the Dartmouth-Hitchcock Medical Center sign. - For real-time driving directions, consider using Waze.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Dartmouth-Hitchcock Medical Center, contact the Dartmouth Health Billing Customer Service team at 844-808-0730. They can assist with billing, payments, insurance plans, and financial assistance policies. Financial assistance applications are available in person at Dartmouth Health locations, over the phone, or via download from the Dartmouth Health website.
What insurance does Dartmouth-Hitchcock Medical Center accept?
Dartmouth-Hitchcock Medical Center accepts the following medical insurance plans: - ElevateHealth HSA Plan - ElevateHealth HRA Plan - Choice Health Plan The ElevateHealth Plans are in partnership with Dartmouth Hitchcock Medical Center and Clinics, Elliot Health System, and Harvard Pilgrim Health Care. The Choice Health Plan provides a national network of providers, covering both in-network and out-of-network providers with varying deductibles and coinsurance.
What awards or recognition has Dartmouth-Hitchcock Medical Center received?
Dartmouth-Hitchcock Medical Center (DHMC) ranks as the highest-scoring hospital in New Hampshire according to Newsweek's America's Best-In-State Hospitals 2024 list. DHMC is also certified as a Comprehensive Stroke Center by The Joint Commission, showcasing its expertise in managing complex stroke cases.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.